UNSPSC 51453001: Piperazine

This classification denotes an antihelminthic agent with the molecular formula C4H10N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1RTM4PAL0V, chemically known as 1,4-piperazine but generally known as piperazine, which bears US NIH Compound Identifier 4837. European Medicines Agency schedules Piperazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03841MIG. World Health Organization schedules piperazine in its Anatomical Therapeutic Chemical (ATC) Classification.

Most nations schedule piperazine under HS 29335990 and SITC 51576. As of Q4 2014, PIPERAZINE remains the US FDA Preferred Term for this commodity. Piperazine bears US NLM identifiers UMLS ID C0031957 and NCI Concept Code C61892. SMILES: C1CNCCN1.

UNSPSC 51453001 Piperazine is a Commodity code that shows minimal alignment with actual state and local procurement activity in recent months. The code nominally describes a specific chemical compound used in pharmaceutical synthesis, yet the recent opportunities tagged to this code center on finished pharmaceutical products, medical supplies, and pharmacy benefit management — naloxone and drug deactivation systems, first-aid and rescue supplies, and generic multi-source pharmaceuticals and OTC products. State and local issuing bodies pursuing these opportunities are county health departments (Seminole County, Florida), city fire and rescue divisions (City of Tampa), state health agencies (Texas HHS Commission), and cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance). None of the recent solicitations actually name or specify piperazine as a component or input material.

Geographic activity in the recent record spans Florida, Texas, Minnesota, and Oregon through the cooperative purchasing vehicle, with no concentration in a single jurisdiction or region. Representative recent opportunities include Seminole County's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually (due July 26, 2023), the City of Tampa's ITB for 169 line items of medical and first aid supplies for its Fire Department Rescue Division with an estimated contract value of $700,000 (due March 13, 2026), and MMCAP's RFP to establish multiple contracts for generic pharmaceuticals and OTC products (due March 26, 2026). The code's recent tagging appears to reflect a classification mismatch rather than active procurement of piperazine itself; state and local procurement activity under this code does not support a business development strategy focused on the chemical or its direct supply.